BeOne Medicines AG (ONC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $46.98B
Last updated: Nov 17, 2026 at 4:15 PM ET
BeOne Medicines AG (ONC) Statistics
BeOne Medicines AG (ONC) has a market cap of $46.98B. Its return on invested capital of 7.51% compares with a 4.83% median across 9 similar companies.
Total Valuation
| Market Cap | $46.98B |
|---|---|
| Latest price (Nov 17, 2026) | $413.26 |
Key Dates
| Last Earnings Date | Nov 5, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 18.8x and 8.3x.
| P/E Ratio | 50.2x |
|---|---|
| P/S Ratio | 18.8x |
| P/B Ratio | 8.3x |
| P/FCF Ratio | 83.6x |
Enterprise Valuation
Counting debt and cash, the company is valued at 73.6x EBITDA and 75.5x free cash flow.
| EV / EBITDA | 73.6x |
|---|---|
| EV / FCF | 75.5x |
Price Statistics
The stock is up 12.97% over 52 weeks and trades 11.25% above its 50-day average.
| Beta (1Y) | 0.67 |
|---|---|
| 52-Week Change | +12.97% |
| 1-Month Change | +11.64% |
| 3-Month Change | +9.66% |
| 6-Month Change | +39.14% |
| 5-Year Change | +3.53% |
| 10-Year Change | +1014.11% |
| Total Return (1Y) | +12.97% |
| Total Return (3Y CAGR) | +30.27% |
| Total Return (5Y CAGR) | +2.29% |
| Return vs SPY (1Y) | +2.00% |
| Max Drawdown (1Y) | -30.89% |
| Max Drawdown (3Y) | -31.06% |
| Sharpe Ratio (1Y) | 0.38 |
| Correlation with SPY (1Y) | 0.27 |
| 50-Day Average | $371.47 |
| 200-Day Average | $328.49 |
| 52-Week Range | $253.95 to $424.73 |
| RSI (14 Days) | 64.5 |
| Average Volume (20 Days) | 451.39K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.55x current liabilities, and total debt is 0.18x shareholder equity.
| Current Ratio | 3.55x |
|---|---|
| Quick Ratio | 3.19x |
| Debt / Equity | 0.18x |
| Debt / EBITDA | 1.81x |
| Interest Coverage | 9.41x |
Returns and Efficiency
Return on invested capital is 7.51% over the last 12 months, against a 5-year average of -15.50%.
| Return on Assets (ROA) | 4.68% |
|---|---|
| Return on Invested Capital (ROIC) | 7.51% |
| ROIC (5Y Average) | -15.50% |
| Inventory Turnover | 0.63x |
| Receivables Turnover | 3.94x |
| Cash Conversion Cycle | 315 days |
Scores
ONC has an Altman Z-Score of 7.26, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 7.26 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Dividends and Yields
ONC does not pay a dividend. Its free cash flow yield is 1.20%.
| Earnings Yield | 1.99% |
|---|---|
| FCF Yield | 1.20% |
Peer Position
Against 7 similar companies, ONC has the 2nd highest P/E.
P/E RatioPeer median 29.8x
P/S RatioPeer median 13.8x
ROICPeer median 4.83%
| P/E Ratio | 50.2x vs 29.8x median |
|---|---|
| P/S Ratio | 18.8x vs 13.8x median |
| ROIC | 7.51% vs 4.83% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ONC
What is ONC's market cap?
BeOne Medicines AG has a market cap of $46.98B.
What is ONC's P/E ratio?
BeOne Medicines AG has a trailing P/E ratio of 50.2x.
How many shares of ONC are outstanding?
BeOne Medicines AG has 117.30M shares outstanding. The count is up 2.43% from a year earlier.
Does ONC pay a dividend?
No. BeOne Medicines AG does not pay a dividend.
ONC pages: Overview, Charting, Statistics, Valuation, Competitors